|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.12 USD | -5.78% |
|
+2.42% | -48.54% |
| 05-07 | Pavmed Inc. Appoints Dennis Matheis to Board of Directors | CI |
| 03-27 | Transcript : PAVmed Inc., Q4 2023 Earnings Call, Mar 27, 2024 |
PAVmed Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 0.377 million compared to USD 0.5 million a year ago. Net loss was USD 88.98 million compared to USD 50.35 million a year ago.
Basic loss per share from continuing operations was USD 1 compared to USD 0.65 a year ago. Diluted loss per share from continuing operations was USD 1 compared to USD 0.65 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -48.54% | 20M | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +13.73% | 52.26B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B |
PAVMED INC. 
